Results 141 to 150 of about 16,374 (258)
Purpose To investigate whether prophylactic use of low‐molecular‐weight heparin (enoxaparin) after knee arthroscopy reduces the incidence of symptomatic venous thromboembolism (VTE) compared with no postoperative pharmacological prophylaxis. Methods We conducted a population‐based cohort study using linked national insurance and hospital data from ...
Aylin Albrecht +5 more
wiley +1 more source
Physician behavior for "invisible" treatment; Korean herbal medicine doctor's treatment covered by auto insurance. [PDF]
Lee C.
europepmc +1 more source
WAYS TO REFORM FOR COMPULSORY MEDICAL INSURANCE FUND IN RUSSIA
Natalia Ivanovna Lyakhova +1 more
openaire +1 more source
Purpose To report conversion rates to total hip arthroplasty (THA), patient‐reported outcome measures, and complication rates in adults aged ≥ 40 years undergoing hip arthroscopy since 2016. Methods MEDLINE, EMBASE, and PubMed were searched from January 2016 to March 2025, and pertinent data were abstracted from eligible studies according to the ...
Helena Son +10 more
wiley +1 more source
Assessing the integration of digitalization and AI in general medicine curricula in German-speaking Europe: a comprehensive survey. [PDF]
Zahn A, Mücke M, Sellin J, Ateş G.
europepmc +1 more source
Purpose To systematically review and report patient‐reported outcome measures (PROMs), rates of return to sport, and secondary surgeries in dancers and flexibility sport athletes who underwent hip arthroscopy. Methods Using the 2020 Preferred Reporting Items for Systematic Reviews and Meta‐Analyses criteria, a systematic review was performed with a ...
David R. Maldonado +2 more
wiley +1 more source
Genomic Medicine and Individual Autonomy: Reflections on Knowledge Societies and Governmentality. [PDF]
Parrish RH.
europepmc +1 more source
Purpose To compare postoperative complications, rehabilitation outcomes, and health care utilization in children undergoing primary medial patellofemoral ligament reconstruction for patellofemoral instability with and without a pre‐existing mental illness. Methods The TriNetX U.S.
Haad A. Arif +4 more
wiley +1 more source
Coverage Generosity of Novel Antirheumatic Drugs in Medicare Advantage and Stand‐Alone Part D Plans
Objective We examine coverage of self‐administered disease‐modifying antirheumatic drugs (DMARDs) in Medicare Part D. Methods Using 2022–2026 Part D formulary data, we assessed coverage of the following DMARD classes that treat relapsed rheumatoid arthritis (RA): tumor necrosis factor (TNF) inhibitors, T cell costimulatory modulator, interleukin‐6 (IL ...
Youngmin Kwon +2 more
wiley +1 more source
The impact of Choosing Wisely<sup>TM</sup> recommendations and insurance coverage restrictions on the provision of low-value care: an interrupted time series analysis of vitamin D tests. [PDF]
Sallin A +6 more
europepmc +1 more source

